文献速递糖尿病

筛查发现的2型糖尿病病例结局更好吗?

Screening for type 2 diabetes: do screen-detected cases fare better?
PubMed 文献 · Diabetologia · 2017-08-23

在瑞典Västerbotten干预计划中,比较1992至2013年间1024例筛查发现与8642例临床发现的糖尿病病例。筛查发现者诊断平均早4.6年,临床发现者全因死亡率更高(HR 2.07,95%CI 1.63-2.62),心血管疾病、肾病和视网膜病变也呈类似模式。筛查发现糖尿病者似乎结局更好,但此关联在多大程度上由早期治疗解释而非健康使用者偏倚、领先时间偏倚和病程长短偏倚,需进一步研究。

要点

  • 筛查发现的糖尿病病例比临床发现者平均早诊断4.6年。
  • 临床发现者全因死亡率高于筛查发现者,HR 2.07(95%CI 1.63-2.62)。
  • 心血管疾病、肾病和视网膜病变的估计值呈类似模式。

核心结论

  • 筛查发现的糖尿病病例诊断更早,在全因死亡率、心血管疾病、肾病和视网膜病变方面似乎结局更好。
  • 这些关联在多大程度上由筛查带来的早期治疗解释而非健康使用者偏倚、领先时间偏倚和病程长短偏倚,需进一步研究。

研究设计与样本

  • Västerbotten干预计划是瑞典Västerbotten县基于社区和个体的公共卫生计划,居民在30、40、50和60岁时受邀接受口服葡萄糖耐量试验(OGTT)筛查糖尿病,符合筛查条件者n=142,037。
  • 1992至2013年间,通过登记数据识别1024例筛查发现和8642例临床发现的糖尿病病例。
  • 临床发现者包括既往筛查参与者(n=4506)和未参与筛查者(n=4136)。
  • 从糖尿病检测日期随访至随访结束、移居、死亡或发生心血管疾病、肾病或视网膜病变事件,采用Cox比例风险回归校正日历时间、检测时年龄、检测年份、性别和社会经济地位进行比较。

主要发现

  • 筛查发现者的平均糖尿病诊断年龄比临床发现者低4.6年。
  • 临床发现者全因死亡率高于筛查发现者,HR 2.07(95%CI 1.63-2.62)。
  • 临床发现的筛查未参与者全因死亡率高于筛查发现者,HR 2.31(95%CI 1.82-2.94);临床发现的既往筛查参与者全因死亡率高于筛查发现者,HR 1.70(95%CI 1.32-2.18)。
  • 心血管疾病、肾病和视网膜病变的估计值呈类似模式。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 这些关联在多大程度上由筛查带来的早期治疗解释而非健康使用者偏倚、领先时间偏倚和病程长短偏倚,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We aimed to investigate whether diabetes cases detected through screening have better health outcomes than clinically detected cases in a population-based cohort of adults who were eligible to be screened for diabetes at 10 year intervals. METHODS: The Västerbotten Intervention Programme is a community- and individual-based public health programme in Västerbotten County, Sweden. Residents are invited to clinical examinations that include screening for diabetes by OGTTs at age 30, 40, 50 and 60 years (individuals eligible for screening, n = 142,037). Between 1992 and 2013, we identified 1024 screen-detected cases and 8642 clinically detected cases of diabetes using registry data. Clinically detected individuals were either prior screening participants (n = 4506) or people who did not participate in screening (non-participants, n = 4136). Study individuals with diabetes were followed from date of detection until end of follow-up, emigration, death or incident cardiovascular disease (CVD), renal disease or retinopathy event, and compared using Cox proportional hazard regression adjusted for calendar time, age at detection, year of detection, sex and socioeconomic status. RESULTS: The average age at diabetes diagnosis was 4.6 years lower for screen-detected individuals compared with clinically detected individuals. Overall, those who were clinically detected had worse health outcomes than those who were screen-detected (HR for all-cause mortality 2.07 [95% CI 1.63, 2.62]). Compared with screen-detected study individuals, all-cause mortality was higher for clinically detected individuals who were screening non-participants (HR 2.31 [95% CI 1.82, 2.94]) than for those clinically detected who were prior screening participants (HR 1.70 [95% CI 1.32, 2.18]). Estimates followed a similar pattern for CVD, renal disease and retinopathy. CONCLUSIONS/INTERPRETATION: Individuals with screen-detected diabetes were diagnosed earlier and appeared to fare better than those who were clinically detected with regard to all-cause mortality, CVD, renal disease and retinopathy. How much of these associations can be explained by earlier treatment because of screening rather than healthy user bias, lead time bias and length time bias warrants further investigation.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Feldman AL, Griffin SJ, Fhärm E, et al. Screening for type 2 diabetes: do screen-detected cases fare better? Diabetologia. 2017. PMID: 28831538. doi:10.1007/s00125-017-4402-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。